Analytical Data
-
基因名
MAGEA6
- Application
-
别名
MAGEA6;MAGE6;Melanoma-associated antigen 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43360
-
表达区间
1-314aa
-
氨基酸序列
MPLEQRSQHC KPEEGLEARG EALGLVGAQA PATEEQEAAS SSSTLVEVTL GEVPAAESPD PPQSPQGASS LPTTMNYPLW SQSYEDSSNQ EEEGPSTFPD LESEFQAALS RKVAKLVHFL LLKYRAREPV TKAEMLGSVV GNWQYFFPVI FSKASDSLQL VFGIELMEVD PIGHVYIFAT CLGLSYDGLL GDNQIMPKTG FLIIILAIIA KEGDCAPEEK IWEELSVLEV FEGREDSIFG DPKKLLTQYF VQENYLEYRQ VPGSDPACYE FLWGPRALIE TSYVKVLHHM VKISGGPRIS YPLLHEWALR EGEELEHHHH HH
-
分子量
36 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant E.coli VD2 Protein，His
Cat：PA2000-415DB
Recombinant Human MAGEA5 Protein，His
Cat：PA1000-1875
Protein Description
MAGEA6 (Melanoma Antigen Gene A6) is a member of the MAGE gene family, which encodes proteins typically expressed in various tumors but not in normal tissues, making them attractive targets for cancer immunotherapy. The unique expression profile of MAGEA6, particularly in melanoma and other cancers, has prompted extensive investigation into its functional roles and potential as a biomarker for tumor diagnosis and prognosis. Researchers have focused on the recombinant production of MAGEA6 protein to facilitate the study of its biological functions and interactions with the immune system. This recombinant protein serves as a crucial tool for developing MAGEA6-targeted immunotherapies, including peptide-based vaccines and adoptive T cell therapies. Additionally, understanding the mechanism of MAGEA6 in tumorigenesis and immune evasion can provide insights into novel therapeutic strategies and enhance our understanding of tumor biology. Overall, the study of MAGEA6 recombinant protein is pivotal in advancing personalized cancer treatments and improving clinical outcomes for patients with malignancies expressing this antigen.
